These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30371507)

  • 21. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
    Maltête D; Jodoin N; Karachi C; Houeto JL; Navarro S; Cornu P; Agid Y; Welter ML
    J Neurophysiol; 2007 Jun; 97(6):4017-22. PubMed ID: 17460099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency matters: beta-band subthalamic nucleus deep-brain stimulation induces Parkinsonian-like blink abnormalities in normal rats.
    Kaminer J; Thakur P; Evinger C
    Eur J Neurosci; 2014 Oct; 40(8):3237-42. PubMed ID: 25146113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oscillations of pause-burst neurons in the STN correlate with the severity of motor signs in Parkinson's disease.
    Belova EМ; Filyushkina VI; Dzhalagoniia I; Gamaleya AA; Tomskiy AA; Neumann WJ; Sedov A
    Exp Neurol; 2022 Oct; 356():114155. PubMed ID: 35772526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.
    Alam M; Heissler HE; Schwabe K; Krauss JK
    Exp Neurol; 2012 Jan; 233(1):233-42. PubMed ID: 22036687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of low frequency stimulation of the pedunculopontine tegmental nucleus on basal ganglia in a rat model of Parkinson's disease.
    Park E; Song I; Jang DP; Kim IY
    Neurosci Lett; 2014 Aug; 577():16-21. PubMed ID: 24928224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subthalamic nucleus deep brain stimulation for Parkinson's disease: current trends and future directions.
    Macerollo A; Zrinzo L; Akram H; Foltynie T; Limousin P
    Expert Rev Med Devices; 2020 Oct; 17(10):1063-1074. PubMed ID: 32250645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthalamic nucleus deep brain stimulation protects neurons by activating autophagy via PP2A inactivation in a rat model of Parkinson's disease.
    Du TT; Chen YC; Lu YQ; Meng FG; Yang H; Zhang JG
    Exp Neurol; 2018 Aug; 306():232-242. PubMed ID: 29792848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ameliorating parkinsonian motor dysfunction by targeting histamine receptors in entopeduncular nucleus-thalamus circuitry.
    Peng JY; Qi ZX; Yan Q; Fan XJ; Shen KL; Huang HW; Lu JH; Wang XQ; Fang XX; Mao L; Ni J; Chen L; Zhuang QX
    Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2216247120. PubMed ID: 37068253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice.
    Schor JS; Gonzalez Montalvo I; Spratt PWE; Brakaj RJ; Stansil JA; Twedell EL; Bender KJ; Nelson AB
    Elife; 2022 Jul; 11():. PubMed ID: 35786442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subthalamic nucleus: from circuits, functions to a deep brain stimulation target for the treatment of Parkinson's disease].
    Li GY; Zhuang QX; Li B; Wang JJ; Zhu JN
    Sheng Li Xue Bao; 2017 Oct; 69(5):611-622. PubMed ID: 29063109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical activity levels in people with Parkinson's disease treated by subthalamic nucleus deep brain stimulation.
    Danoudis M; Iansek R
    Disabil Rehabil; 2023 Sep; 45(18):2890-2895. PubMed ID: 36124542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.
    Lin TP; Carbon M; Tang C; Mogilner AY; Sterio D; Beric A; Dhawan V; Eidelberg D
    Brain; 2008 May; 131(Pt 5):1373-80. PubMed ID: 18400841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Search of a Feedback Signal for Closed-Loop Deep Brain Stimulation: Stimulation of the Subthalamic Nucleus Reveals Altered Glutamate Dynamics in the Globus Pallidus in Anesthetized, 6-Hydroxydopamine-Treated Rats.
    Chernov MM; Swan CB; Leiter JC
    Biosensors (Basel); 2023 Apr; 13(4):. PubMed ID: 37185555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connectivity and Dynamics Underlying Synaptic Control of the Subthalamic Nucleus.
    Steiner LA; Barreda Tomás FJ; Planert H; Alle H; Vida I; Geiger JRP
    J Neurosci; 2019 Mar; 39(13):2470-2481. PubMed ID: 30700533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthalamic Deep Brain Stimulation Affects Plasma Corticosterone Concentration and Peripheral Immunity Changes in Rat Model of Parkinson's Disease.
    Grembecka B; Glac W; Listowska M; Jerzemowska G; Plucińska K; Majkutewicz I; Badtke P; Wrona D
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):454-469. PubMed ID: 32648088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
    Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's disease uncovers an underlying sensitivity of subthalamic nucleus neurons to beta-frequency cortical input in vivo.
    Baaske MK; Kormann E; Holt AB; Gulberti A; McNamara CG; Pötter-Nerger M; Westphal M; Engel AK; Hamel W; Brown P; Moll CKE; Sharott A
    Neurobiol Dis; 2020 Dec; 146():105119. PubMed ID: 32991998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.